About Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP)
Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) is a public, development-stage biopharmaceutical company that develops drugs to treat gastrointestinal disorders and diseases. Our patented drug candidates, currently in clinical development, were discovered and developed in-house by Synergy scientists. Synergy’s lead investigational drug, PLECANATIDE, is designed to treat Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome. Get more information about us at www.synergypharma.com Specialties Innovative GI Therapeutics, Chronic Constipation and Irritable Bowel Syndrome, Inflammatory Bowel Disease, Guanylate Cyclase C agonists for GI disorders and diseases
Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) Job Openings
Create job profile to receive interview calls for your dream job
Create Job Alert Kick Start! your career with best matching jobs
Location
X